MYH14 and viral myocarditis: The EAM immunization protocol is used as a model of the chronic inflammatory phase of post-viral myocarditis (13), characterized by ongoing inflammation, fibrotic remodeling, appearance of anti-myosin antibodies, and development of DCM in the end-stage (63).